Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
FDC Ltd share price today (on 3 December 2023).
We Provide Best stock tips for FDC Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of FDC Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for FDC Ltd
BSE: 531599 | NSE: FDC | ISIN: INE258B01022 Market Cap: [Rs.Cr.] 1,681 | Face Value: [Rs.] 1 Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
FDC Limited manufactures and markets various healthcare products in India and internationally. The company offers therapeutics, foods, and bulk drugs. Its therapeutic and food products include anti fungals/dermatological, anti-anaemic, anti-diabetic, anti-diarrhoeals/intestinals/ORS, anti-haemorrhagics, anti-oxidants, anti-spasmodics, antibiotics/antibacterials, antiemetic/antinauseant, antimalarials, antiulcerants, antivirals, calcium supplements, cardio-vascular, central nervous system, ENT
Promoted as a partnership firm in 1936 by the late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods Fairdeal Corporation (P) Ltd, as the company was known, was converted into a private limited company in 1940. It set up a formulation unit at Jogeshwari, Bombay in 1949. FDC's subsidiaries are FDC Holdings, Netherlands B V, FDC International Ltd,UK and FDC Inc,New Jersey ,USA . Fair Deal Corporation Pharmaceutical SA (Pty) Ltd is its Joint Venture Entity. The company manufactures Electral, oral rehydration salt (ORS), being a leader in this segment with market share has improved from 1.24% to 1.32% and its market rank has improved from 25th to 22nd. FDC manufactures bulk drugs, formulations and food products. The plant at Roha manufactures pharma dosage forms, food products and bulk drugs for the anti-rheumatic, anti-asthmatic, opthalmic and ENT segments. The company part financed its technical upgradation/modernisation/backward integration/expansion plans from the proceeds of its initial public issue in Jan.'96. The company set up a modern manufacturing plant at Goa for manufacture of tablet dosage forms. The plant has commenced commercial production in Sep 2000.
The plant is designed to meet UK/US standards on solid dosage form. In Feb. 2001, the company has signed a marketing tie-updeal with Aspen Pharmacare of South Africa. Through this alliance, FDC will be initially marketing 10-12 ophthalmic products manufactured at its plants in India and approved by the UK Medicines Control Agency in South Africa. FDC will also enter into a licensing arrangement with Aspen Pharmacare for solid dosage forms and oral rehydration salts, to be manufactured locally in South Africa at Aspen's facilities with knowhow from FDC. Aspen Pharmacare is the largest listed pharmaceutical company in South Africa and a dominant player in generic medicine. The total market for ophthalmic products in South Africa is estimated at Rs. 78.70 cr, and FDC hopes to achieve a 30% marketshare in five years. During 2000-01, the company's Roha plant, manufacturing basic raw materials, was inspected and approved by US FDA. The company is also setting up a modern manufacturing plant at a separate site in Goa. The plant will be a world class facilities with quality systems of International GMP Standards and it will also enable the company to enter into US market. The trial runs and commerical production is expected to be commenced in March 2004. To tap the Sub Sahara African countries FDC is planning to set up a marketing joint venture in South Africa and Russia. FDC is setting up a manufacturing facility at Baddi, Himachal Pradesh, for the manufacturing of Cephalosporin drugs. This facility is expected to be operational in 2006.
The company has received approvel from US FDA for its sterile manufacturing facility for ophthamlmic dosage forms at Waluj, Aurangabad and an analytical research and devrelopment laboratory at Jogeshwari, Mumbai. Also the company is setting up an additional facility at Waluj by adding one more Form-Fill-Seal(FFS) machine during the year 2004-05. During the year 2004-2005, FDC has received a certification for its plant at Waluj conforms to the Quality Management System Standards ISO 9001:2000 and ISO13485:2003 respectively. This will enable the company to enhance its exports to European countries. In the year 2004-05, the company has issued bonus equity shares in the ratio of 1:1. In 2006, The company has expanded its installed capacity of Basic Drugs, Capsules and Formulations (Cream, Powder, Ointments etc.) by 2350 kgs, 20,00,000 nos and 1342200 kgs respectively during the year. With this expansion the total capacity of Basic Drugs, Capsules and Formulations (Cream, Powder, Ointments, etc) has been increased to 119050 kgs, 19.20 nos in crores and 77,77,920 respectively. The company has set up a production facility at Baddi, Himachalpradesh, the production at this new site will commence from July 2006.
1940- The Company was Incorporated as a private limited company on 23rd September and converted into public limited company on 16th Sept. 1988. The Company was promoted as a partnership firm in 1936 by Late Mr. Anand Chandavarkar for the import of pharmaceutical dosage forms, specialised infant foods and surgical goods. It was converted into a Pvt. Ltd. Company under the name Fairdeal Corporation Pvt. Ltd. in Mumbai.
1949- A formulation unit was set up at Jogeshwari.
- During the mid seventies, the Company went in for a backward integration by setting up a unit for manufacture of basic drugs at Roha.
1985 - Effective 24th June, the name of the Company was changed to FDC Pvt. Ltd.
1991 - A biotechnology based R & D division was set up at Waluj. Bulk drugs one formulated into injectables, tablets and capsules at the Jogeshwari Plant.
1993- The Company commissioned a new unit at Waluj for manufacture of ophthalmic products using the labour from latest form/fill/seal technology.
1995- 72,75,000 No. of equity shares issued to promoters, directors etc. 27,28,200 No. of equity shares were issued at a premium of Rs 90 per share on 29th January 1996 of which 1,00,000 shares reserved and allotted to Directors, their friends, relatives and associates. Of the remaining 15,000 shares to UTI on firm allotment.- Another 1,12,400 shares issued to employees on preferential basis (only 53,000 shares taken up). Balance 25,00,800 shares issued to the public along with 59,400 shares from employees quota (13,36,980 shares taken up).
1996 - The Company introduced for the first time a unique dosage form of ophthalmics in the form of unit dose without preservating.- A modern biotechnology Lab was set up at Jogeshwari for Research and Development.- The Company proposed to give a major thrust on computerisation by switching over from the existing modular hardware and software on to an integrated RDBMS to facilitate dissemination of information throughout the organisation.- It was also proposed to set up a communication network by acquiring VSATS for linking all existing units with Corporate Office.- Fresh capacities were proposed to be built up for bull drugs viz., cinnarizone at 500 Kgs p.a. and Floravizine at 120 kgs. per annum.
- The Company undertook to technically upgrade the capacity in the ophthalmic dosages segment by installing a Form-fill-seal (FFS) machine at its plant in Waluj.- The Company undertook to set up two independent units adjacent to each other at Sinnar, Nasik for manufacture of penicillin based antibiotic formulations including sterile injectables, tablets, capsules etc.
2000 - The company has launched Reliter, a dietart supplement for people over 49 with active lifestyles.
2001 - The Rs. 150 crore FDC, best-known for its rehydration sale electral has tied up with Aspen Pharmacre to sell its ophthalmic products in South Africa.- FDC Ltd, makers of the popular Electral brand, has launched Simyl MCTOil -- a naturitional supplement for children and adults suffering from inadequate fat absorption.- The Company has launched Simyl MCT Oil, claimed to be unique nutritional supplement for children and adults suffering from inadequate fat absorption.
2002-Ms Shalini Shenoy is appointed as the Compliance Officer of the company.
2003 - Received GMP accreditation from the Medicines Control Council (MCC) of the Republic of South Africa, for registration of Oral powders and Sterile Ophthalmic dosages.-Mr. Rohit R Chandavarkar, the company's Wholetime Director has passed away on October 29, 2003.
2005-FDC receives CE mark approval for its 2 products from DNV - Norway
2009- Fdc Ltd has appointed Mr. Ameya A. Chandavarkar, as a whole time director of the Company w.e.f. November 01, 2009
( Equity cash, Nse fno, jackpot call, sure shot call, btst/stbt call )
Under one plan with Unbelievable lowest price
for free trial visit www.a1intradaytips.in
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
